US2013028884A1PendingUtilityA1
Composition and method for treatment of bruising
Est. expiryNov 18, 2028(~2.3 yrs left)· nominal 20-yr term from priority
Inventors:Joel R. Studin
A61P 29/00A61K 9/006A61P 17/16A61K 9/0014A61K 36/28A61P 17/00A61K 38/4873A61K 36/15A61K 45/06
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
There is provided a skin treatment composition for oral or topical administration and a method for skin treatment. The composition comprises a chelating agent and at least one protease. The composition helps to remove hemosiderin that causes staining of skin on a bruised area and reduces inflammation and pain.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . (canceled)
3 . (canceled)
4 . (canceled)
5 . A skin treatment composition, in the form of a kit comprising a chelating agent in an effective amount to remove hemosiderin from the body and reduce the staining of a bruised area of the skin, at least one protease and Arnica Montana extract as a separate oral dosage form.
6 . The skin treatment composition of claim 5 , wherein the chelating agent is phytic acid.
7 . The skin treatment composition of claim 5 , wherein the protease is bromelain.
8 . The skin treatment composition of claim 5 , further comprising at least one of rutin, zinc, pine tree extract, vitamin K, vitamin C, vitamin E or coenzyme Q10.
9 . The skin treatment composition of claim 8 comprising: about 25-75 mg phytic acid, about 150-300 mg bromelain, about 50-100 mg rutin, about 2-3 mg zinc, about 30-40 mg pine tree bark extract, about 10-15 mcg vitamin K, about 100-150 mg vitamin C, about 30-40 IU vitamin E, and about 5-15 mg coenzyme Q10.
10 . The skin treatment composition of claim 9 , comprising about 30 c Arnica montana extract.
11 . The skin treatment composition of claim 10 , comprising about 1 M Arnica montana extract.
12 . (canceled)
13 . The skin treatment composition of claim 5 , wherein said Arnica montana extract is in a sublingual dosage form.
14 . The skin treatment composition of claim 13 , wherein said chelating agent and protease are combined in a single swallowable dosage form.
15 . (canceled)
16 . (canceled)
17 . (canceled)
18 . (canceled)
19 . (canceled)
20 . (canceled)
21 . A method of skin treatment comprising oral administration of a composition comprising a chelating agent, at least one protease and a separate oral administration of Arnica montana extract.Join the waitlist — get patent alerts
Track US2013028884A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.